|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 39/39 | |
| A61K 9/127 | |||
| A61K 9/00 |
| (11) | Number of the document | 1432442 |
| (13) | Kind of document | T |
| (96) | European patent application number | 02777259.9 |
| Date of filing the European patent application | 2002-09-30 | |
| (97) | Date of publication of the European application | 2004-06-30 |
| (45) | Date of publication and mention of the grant of the patent | 2007-01-03 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/EP2002/010931 |
| Date | 2002-09-30 |
| (87) | Number | WO 2003/028760 |
| Date | 2003-04-10 |
| (30) | Number | Date | Country code |
| 0123580 | 2001-10-01 | GB |
| (72) |
GARCON, Nathalie c/o GlaxoSmithKline Beecham, BE
|
| (73) |
GlaxoSmithKline Biologicals s.a.,
rue de l`Institut 89, 1330 Rixensart,
BE
|
| (54) | The use of liposomes containing saponins and sterols in the manufacture of intradermal vaccines |
| The use of liposomes containing saponins and sterols in the manufacture of intradermal vaccines |